A

AYTU

Aytu Biopharma Inc

1.25

0.04+3.05%
After Hours: 1.290  +0.040  +3.20%17:48 05/09 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

118.09M

136.46M

137.62M

265.67M

153.29M

Total Current Assets

61.89M

72.83M

59.93M

105.23M

75.42M

Total Non Current Assets

56.20M

63.63M

77.69M

160.43M

77.87M

Total Liabilities

90.38M

97.11M

91.53M

128.10M

58.28M

Total Current Liabilities

62.23M

69.02M

64.44M

109.44M

28.76M

Total Non Current Liabilities

28.15M

28.09M

27.09M

18.66M

29.51M

Total Equity

27.72M

39.36M

46.09M

137.57M

95.02M

Total Stockholders Equity

27.72M

39.36M

46.09M

137.57M

95.02M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

118.09M

136.46M

137.62M

265.67M

153.29M

Total Common Shares Outstanding

5.97M

5.52M

1.93M

1.37M

629.19K

Total Preferred Shares Outstanding

--

--

--

0

0